Skip to main content
New Year’s Sale — Build a balanced news diet with 40% off Vantage
Get Started
SubscribeLogin
Published • loading... • Updated

Phase 3 Trial of Calderasib Combo Launched in Advanced KRAS G12C-Mutant NSCLC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

Summary by targetedonc.com
A new trial explores the effectiveness of calderasib combined with pembrolizumab for advanced lung cancer patients with the KRAS G12C mutation.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

3 Articles

targetedonc.comtargetedonc.com

Phase 3 Trial of Calderasib Combo Launched in Advanced KRAS G12C-Mutant NSCLC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

A new trial explores the effectiveness of calderasib combined with pembrolizumab for advanced lung cancer patients with the KRAS G12C mutation.

Read Full Article
Clinical Trials ArenaClinical Trials Arena

MSD begins KANDLELIT-007 trial of calderasib for NSCLC

MSD has commenced the KANDLELIT-007 Phase III trial to assess calderasib, with Keytruda Qlex in patients with advanced or metastatic NSCLC.The post MSD begins KANDLELIT-007 trial of calderasib for NSCLC appeared first on Clinical Trials Arena.

Read Full Article
cancernetwork.comcancernetwork.com

Investigators Launch Phase 3 Trial of Calderasib Combo in Advanced NSCLC

The randomized KANDLELIT-007 trial will enroll approximately 675 patients with advanced non–small cell lung cancer across the world.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

cancernetwork.com broke the news in on Wednesday, January 7, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal